Cisplatin + docetaxel improves survival over cisplatin + mitomycin C in hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei: a retrospective study based on propensity score matching
Following CRS, the CD regimen offers superior survival benefits compared to the CM regimen for PMP patients. These findings highlight the potential of personalized HIPEC strategies to optimize outcomes for PMP treatment.
Authors
- Yu‐Bin Fu
- Yan‐Dong Su
- Ru Ma (ORCID: https://orcid.org/0000-0002-6843-5129)
- Tian Wei (ORCID: https://orcid.org/0000-0002-0612-0076)
- Rui Yang (ORCID: https://orcid.org/0000-0003-2291-4914)
- Bing Keong Li (ORCID: https://orcid.org/0000-0001-6983-7253)
- Yan Li (ORCID: https://orcid.org/0000-0001-6018-6538)
- Yang Yu (ORCID: https://orcid.org/0000-0002-8482-4626)
Institutions
- Capital Medical University (CN)
- Beijing Tsinghua Chang Gung Hospital (CN)
- Beijing Shijitan Hospital (CN)
- Tsinghua University (CN)
Publication Details
- Journal
- International Journal of Hyperthermia
- Published
- 2025-04-27
- DOI
- https://doi.org/10.1080/02656736.2025.2467296
- Primary Topic
- Intraperitoneal and Appendiceal Malignancies
- Type
- article
- Field-Weighted Citation Impact
- 0.00